Request for Covid-19 Impact Assessment of this Report
The United States Oxcarbazepine Tablets market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Oxcarbazepine Tablets market, reaching US$ million by the year 2028. As for the Europe Oxcarbazepine Tablets landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Oxcarbazepine Tablets players cover Novartis (Trileptal), Supernus Pharmaceuticals (Oxtellar XR), Apotex, and Sun Pharm, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Oxcarbazepine Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Tablets (150mg)
Tablets (300mg)
Tablets (600mg)
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Novartis (Trileptal)
Supernus Pharmaceuticals (Oxtellar XR)
Apotex
Sun Pharm
Jubilant Generics
Taro Pharmaceuticals
Stada Group
Mylan
Teva Pharmaceutical
Hikma Pharmaceuticals
ANI Pharmaceuticals
Glenmark Pharmaceuticals
Roxane Laboratories
Nobelpharma
Jamp Pharma
Neuraxpharm
Orion Corporation
SihuanPharm
Humanwell Healthcare
Huikang Pharmaceutical
Nexgen pharma
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oxcarbazepine Tablets Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Oxcarbazepine Tablets by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Oxcarbazepine Tablets by Country/Region, 2017, 2022 & 2028
2.2 Oxcarbazepine Tablets Segment by Type
2.2.1 Tablets (150mg)
2.2.2 Tablets (300mg)
2.2.3 Tablets (600mg)
2.3 Oxcarbazepine Tablets Sales by Type
2.3.1 Global Oxcarbazepine Tablets Sales Market Share by Type (2017-2022)
2.3.2 Global Oxcarbazepine Tablets Revenue and Market Share by Type (2017-2022)
2.3.3 Global Oxcarbazepine Tablets Sale Price by Type (2017-2022)
2.4 Oxcarbazepine Tablets Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.4.3 Online Pharmacy
2.5 Oxcarbazepine Tablets Sales by Application
2.5.1 Global Oxcarbazepine Tablets Sale Market Share by Application (2017-2022)
2.5.2 Global Oxcarbazepine Tablets Revenue and Market Share by Application (2017-2022)
2.5.3 Global Oxcarbazepine Tablets Sale Price by Application (2017-2022)
3 Global Oxcarbazepine Tablets by Company
3.1 Global Oxcarbazepine Tablets Breakdown Data by Company
3.1.1 Global Oxcarbazepine Tablets Annual Sales by Company (2020-2022)
3.1.2 Global Oxcarbazepine Tablets Sales Market Share by Company (2020-2022)
3.2 Global Oxcarbazepine Tablets Annual Revenue by Company (2020-2022)
3.2.1 Global Oxcarbazepine Tablets Revenue by Company (2020-2022)
3.2.2 Global Oxcarbazepine Tablets Revenue Market Share by Company (2020-2022)
3.3 Global Oxcarbazepine Tablets Sale Price by Company
3.4 Key Manufacturers Oxcarbazepine Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oxcarbazepine Tablets Product Location Distribution
3.4.2 Players Oxcarbazepine Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Oxcarbazepine Tablets by Geographic Region
4.1 World Historic Oxcarbazepine Tablets Market Size by Geographic Region (2017-2022)
4.1.1 Global Oxcarbazepine Tablets Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Oxcarbazepine Tablets Annual Revenue by Geographic Region
4.2 World Historic Oxcarbazepine Tablets Market Size by Country/Region (2017-2022)
4.2.1 Global Oxcarbazepine Tablets Annual Sales by Country/Region (2017-2022)
4.2.2 Global Oxcarbazepine Tablets Annual Revenue by Country/Region
4.3 Americas Oxcarbazepine Tablets Sales Growth
4.4 APAC Oxcarbazepine Tablets Sales Growth
4.5 Europe Oxcarbazepine Tablets Sales Growth
4.6 Middle East & Africa Oxcarbazepine Tablets Sales Growth
5 Americas
5.1 Americas Oxcarbazepine Tablets Sales by Country
5.1.1 Americas Oxcarbazepine Tablets Sales by Country (2017-2022)
5.1.2 Americas Oxcarbazepine Tablets Revenue by Country (2017-2022)
5.2 Americas Oxcarbazepine Tablets Sales by Type
5.3 Americas Oxcarbazepine Tablets Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oxcarbazepine Tablets Sales by Region
6.1.1 APAC Oxcarbazepine Tablets Sales by Region (2017-2022)
6.1.2 APAC Oxcarbazepine Tablets Revenue by Region (2017-2022)
6.2 APAC Oxcarbazepine Tablets Sales by Type
6.3 APAC Oxcarbazepine Tablets Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Oxcarbazepine Tablets by Country
7.1.1 Europe Oxcarbazepine Tablets Sales by Country (2017-2022)
7.1.2 Europe Oxcarbazepine Tablets Revenue by Country (2017-2022)
7.2 Europe Oxcarbazepine Tablets Sales by Type
7.3 Europe Oxcarbazepine Tablets Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oxcarbazepine Tablets by Country
8.1.1 Middle East & Africa Oxcarbazepine Tablets Sales by Country (2017-2022)
8.1.2 Middle East & Africa Oxcarbazepine Tablets Revenue by Country (2017-2022)
8.2 Middle East & Africa Oxcarbazepine Tablets Sales by Type
8.3 Middle East & Africa Oxcarbazepine Tablets Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oxcarbazepine Tablets
10.3 Manufacturing Process Analysis of Oxcarbazepine Tablets
10.4 Industry Chain Structure of Oxcarbazepine Tablets
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oxcarbazepine Tablets Distributors
11.3 Oxcarbazepine Tablets Customer
12 World Forecast Review for Oxcarbazepine Tablets by Geographic Region
12.1 Global Oxcarbazepine Tablets Market Size Forecast by Region
12.1.1 Global Oxcarbazepine Tablets Forecast by Region (2023-2028)
12.1.2 Global Oxcarbazepine Tablets Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oxcarbazepine Tablets Forecast by Type
12.7 Global Oxcarbazepine Tablets Forecast by Application
13 Key Players Analysis
13.1 Novartis (Trileptal)
13.1.1 Novartis (Trileptal) Company Information
13.1.2 Novartis (Trileptal) Oxcarbazepine Tablets Product Offered
13.1.3 Novartis (Trileptal) Oxcarbazepine Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Novartis (Trileptal) Main Business Overview
13.1.5 Novartis (Trileptal) Latest Developments
13.2 Supernus Pharmaceuticals (Oxtellar XR)
13.2.1 Supernus Pharmaceuticals (Oxtellar XR) Company Information
13.2.2 Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Tablets Product Offered
13.2.3 Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Supernus Pharmaceuticals (Oxtellar XR) Main Business Overview
13.2.5 Supernus Pharmaceuticals (Oxtellar XR) Latest Developments
13.3 Apotex
13.3.1 Apotex Company Information
13.3.2 Apotex Oxcarbazepine Tablets Product Offered
13.3.3 Apotex Oxcarbazepine Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Apotex Main Business Overview
13.3.5 Apotex Latest Developments
13.4 Sun Pharm
13.4.1 Sun Pharm Company Information
13.4.2 Sun Pharm Oxcarbazepine Tablets Product Offered
13.4.3 Sun Pharm Oxcarbazepine Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Sun Pharm Main Business Overview
13.4.5 Sun Pharm Latest Developments
13.5 Jubilant Generics
13.5.1 Jubilant Generics Company Information
13.5.2 Jubilant Generics Oxcarbazepine Tablets Product Offered
13.5.3 Jubilant Generics Oxcarbazepine Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Jubilant Generics Main Business Overview
13.5.5 Jubilant Generics Latest Developments
13.6 Taro Pharmaceuticals
13.6.1 Taro Pharmaceuticals Company Information
13.6.2 Taro Pharmaceuticals Oxcarbazepine Tablets Product Offered
13.6.3 Taro Pharmaceuticals Oxcarbazepine Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Taro Pharmaceuticals Main Business Overview
13.6.5 Taro Pharmaceuticals Latest Developments
13.7 Stada Group
13.7.1 Stada Group Company Information
13.7.2 Stada Group Oxcarbazepine Tablets Product Offered
13.7.3 Stada Group Oxcarbazepine Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Stada Group Main Business Overview
13.7.5 Stada Group Latest Developments
13.8 Mylan
13.8.1 Mylan Company Information
13.8.2 Mylan Oxcarbazepine Tablets Product Offered
13.8.3 Mylan Oxcarbazepine Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Mylan Main Business Overview
13.8.5 Mylan Latest Developments
13.9 Teva Pharmaceutical
13.9.1 Teva Pharmaceutical Company Information
13.9.2 Teva Pharmaceutical Oxcarbazepine Tablets Product Offered
13.9.3 Teva Pharmaceutical Oxcarbazepine Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Teva Pharmaceutical Main Business Overview
13.9.5 Teva Pharmaceutical Latest Developments
13.10 Hikma Pharmaceuticals
13.10.1 Hikma Pharmaceuticals Company Information
13.10.2 Hikma Pharmaceuticals Oxcarbazepine Tablets Product Offered
13.10.3 Hikma Pharmaceuticals Oxcarbazepine Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Hikma Pharmaceuticals Main Business Overview
13.10.5 Hikma Pharmaceuticals Latest Developments
13.11 ANI Pharmaceuticals
13.11.1 ANI Pharmaceuticals Company Information
13.11.2 ANI Pharmaceuticals Oxcarbazepine Tablets Product Offered
13.11.3 ANI Pharmaceuticals Oxcarbazepine Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 ANI Pharmaceuticals Main Business Overview
13.11.5 ANI Pharmaceuticals Latest Developments
13.12 Glenmark Pharmaceuticals
13.12.1 Glenmark Pharmaceuticals Company Information
13.12.2 Glenmark Pharmaceuticals Oxcarbazepine Tablets Product Offered
13.12.3 Glenmark Pharmaceuticals Oxcarbazepine Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Glenmark Pharmaceuticals Main Business Overview
13.12.5 Glenmark Pharmaceuticals Latest Developments
13.13 Roxane Laboratories
13.13.1 Roxane Laboratories Company Information
13.13.2 Roxane Laboratories Oxcarbazepine Tablets Product Offered
13.13.3 Roxane Laboratories Oxcarbazepine Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Roxane Laboratories Main Business Overview
13.13.5 Roxane Laboratories Latest Developments
13.14 Nobelpharma
13.14.1 Nobelpharma Company Information
13.14.2 Nobelpharma Oxcarbazepine Tablets Product Offered
13.14.3 Nobelpharma Oxcarbazepine Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Nobelpharma Main Business Overview
13.14.5 Nobelpharma Latest Developments
13.15 Jamp Pharma
13.15.1 Jamp Pharma Company Information
13.15.2 Jamp Pharma Oxcarbazepine Tablets Product Offered
13.15.3 Jamp Pharma Oxcarbazepine Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Jamp Pharma Main Business Overview
13.15.5 Jamp Pharma Latest Developments
13.16 Neuraxpharm
13.16.1 Neuraxpharm Company Information
13.16.2 Neuraxpharm Oxcarbazepine Tablets Product Offered
13.16.3 Neuraxpharm Oxcarbazepine Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Neuraxpharm Main Business Overview
13.16.5 Neuraxpharm Latest Developments
13.17 Orion Corporation
13.17.1 Orion Corporation Company Information
13.17.2 Orion Corporation Oxcarbazepine Tablets Product Offered
13.17.3 Orion Corporation Oxcarbazepine Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Orion Corporation Main Business Overview
13.17.5 Orion Corporation Latest Developments
13.18 SihuanPharm
13.18.1 SihuanPharm Company Information
13.18.2 SihuanPharm Oxcarbazepine Tablets Product Offered
13.18.3 SihuanPharm Oxcarbazepine Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 SihuanPharm Main Business Overview
13.18.5 SihuanPharm Latest Developments
13.19 Humanwell Healthcare
13.19.1 Humanwell Healthcare Company Information
13.19.2 Humanwell Healthcare Oxcarbazepine Tablets Product Offered
13.19.3 Humanwell Healthcare Oxcarbazepine Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Humanwell Healthcare Main Business Overview
13.19.5 Humanwell Healthcare Latest Developments
13.20 Huikang Pharmaceutical
13.20.1 Huikang Pharmaceutical Company Information
13.20.2 Huikang Pharmaceutical Oxcarbazepine Tablets Product Offered
13.20.3 Huikang Pharmaceutical Oxcarbazepine Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Huikang Pharmaceutical Main Business Overview
13.20.5 Huikang Pharmaceutical Latest Developments
13.21 Nexgen pharma
13.21.1 Nexgen pharma Company Information
13.21.2 Nexgen pharma Oxcarbazepine Tablets Product Offered
13.21.3 Nexgen pharma Oxcarbazepine Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.21.4 Nexgen pharma Main Business Overview
13.21.5 Nexgen pharma Latest Developments
14 Research Findings and Conclusion
Table 1. Oxcarbazepine Tablets Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Oxcarbazepine Tablets Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Tablets (150mg)
Table 4. Major Players of Tablets (300mg)
Table 5. Major Players of Tablets (600mg)
Table 6. Global Oxcarbazepine Tablets Sales by Type (2017-2022) & (M Unit)
Table 7. Global Oxcarbazepine Tablets Sales Market Share by Type (2017-2022)
Table 8. Global Oxcarbazepine Tablets Revenue by Type (2017-2022) & ($ million)
Table 9. Global Oxcarbazepine Tablets Revenue Market Share by Type (2017-2022)
Table 10. Global Oxcarbazepine Tablets Sale Price by Type (2017-2022) & (USD/Unit)
Table 11. Global Oxcarbazepine Tablets Sales by Application (2017-2022) & (M Unit)
Table 12. Global Oxcarbazepine Tablets Sales Market Share by Application (2017-2022)
Table 13. Global Oxcarbazepine Tablets Revenue by Application (2017-2022)
Table 14. Global Oxcarbazepine Tablets Revenue Market Share by Application (2017-2022)
Table 15. Global Oxcarbazepine Tablets Sale Price by Application (2017-2022) & (USD/Unit)
Table 16. Global Oxcarbazepine Tablets Sales by Company (2020-2022) & (M Unit)
Table 17. Global Oxcarbazepine Tablets Sales Market Share by Company (2020-2022)
Table 18. Global Oxcarbazepine Tablets Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Oxcarbazepine Tablets Revenue Market Share by Company (2020-2022)
Table 20. Global Oxcarbazepine Tablets Sale Price by Company (2020-2022) & (USD/Unit)
Table 21. Key Manufacturers Oxcarbazepine Tablets Producing Area Distribution and Sales Area
Table 22. Players Oxcarbazepine Tablets Products Offered
Table 23. Oxcarbazepine Tablets Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Oxcarbazepine Tablets Sales by Geographic Region (2017-2022) & (M Unit)
Table 27. Global Oxcarbazepine Tablets Sales Market Share Geographic Region (2017-2022)
Table 28. Global Oxcarbazepine Tablets Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Oxcarbazepine Tablets Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Oxcarbazepine Tablets Sales by Country/Region (2017-2022) & (M Unit)
Table 31. Global Oxcarbazepine Tablets Sales Market Share by Country/Region (2017-2022)
Table 32. Global Oxcarbazepine Tablets Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Oxcarbazepine Tablets Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Oxcarbazepine Tablets Sales by Country (2017-2022) & (M Unit)
Table 35. Americas Oxcarbazepine Tablets Sales Market Share by Country (2017-2022)
Table 36. Americas Oxcarbazepine Tablets Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Oxcarbazepine Tablets Revenue Market Share by Country (2017-2022)
Table 38. Americas Oxcarbazepine Tablets Sales by Type (2017-2022) & (M Unit)
Table 39. Americas Oxcarbazepine Tablets Sales Market Share by Type (2017-2022)
Table 40. Americas Oxcarbazepine Tablets Sales by Application (2017-2022) & (M Unit)
Table 41. Americas Oxcarbazepine Tablets Sales Market Share by Application (2017-2022)
Table 42. APAC Oxcarbazepine Tablets Sales by Region (2017-2022) & (M Unit)
Table 43. APAC Oxcarbazepine Tablets Sales Market Share by Region (2017-2022)
Table 44. APAC Oxcarbazepine Tablets Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Oxcarbazepine Tablets Revenue Market Share by Region (2017-2022)
Table 46. APAC Oxcarbazepine Tablets Sales by Type (2017-2022) & (M Unit)
Table 47. APAC Oxcarbazepine Tablets Sales Market Share by Type (2017-2022)
Table 48. APAC Oxcarbazepine Tablets Sales by Application (2017-2022) & (M Unit)
Table 49. APAC Oxcarbazepine Tablets Sales Market Share by Application (2017-2022)
Table 50. Europe Oxcarbazepine Tablets Sales by Country (2017-2022) & (M Unit)
Table 51. Europe Oxcarbazepine Tablets Sales Market Share by Country (2017-2022)
Table 52. Europe Oxcarbazepine Tablets Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Oxcarbazepine Tablets Revenue Market Share by Country (2017-2022)
Table 54. Europe Oxcarbazepine Tablets Sales by Type (2017-2022) & (M Unit)
Table 55. Europe Oxcarbazepine Tablets Sales Market Share by Type (2017-2022)
Table 56. Europe Oxcarbazepine Tablets Sales by Application (2017-2022) & (M Unit)
Table 57. Europe Oxcarbazepine Tablets Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Oxcarbazepine Tablets Sales by Country (2017-2022) & (M Unit)
Table 59. Middle East & Africa Oxcarbazepine Tablets Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Oxcarbazepine Tablets Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Oxcarbazepine Tablets Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Oxcarbazepine Tablets Sales by Type (2017-2022) & (M Unit)
Table 63. Middle East & Africa Oxcarbazepine Tablets Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Oxcarbazepine Tablets Sales by Application (2017-2022) & (M Unit)
Table 65. Middle East & Africa Oxcarbazepine Tablets Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Oxcarbazepine Tablets
Table 67. Key Market Challenges & Risks of Oxcarbazepine Tablets
Table 68. Key Industry Trends of Oxcarbazepine Tablets
Table 69. Oxcarbazepine Tablets Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Oxcarbazepine Tablets Distributors List
Table 72. Oxcarbazepine Tablets Customer List
Table 73. Global Oxcarbazepine Tablets Sales Forecast by Region (2023-2028) & (M Unit)
Table 74. Global Oxcarbazepine Tablets Sales Market Forecast by Region
Table 75. Global Oxcarbazepine Tablets Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Oxcarbazepine Tablets Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Oxcarbazepine Tablets Sales Forecast by Country (2023-2028) & (M Unit)
Table 78. Americas Oxcarbazepine Tablets Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Oxcarbazepine Tablets Sales Forecast by Region (2023-2028) & (M Unit)
Table 80. APAC Oxcarbazepine Tablets Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Oxcarbazepine Tablets Sales Forecast by Country (2023-2028) & (M Unit)
Table 82. Europe Oxcarbazepine Tablets Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Oxcarbazepine Tablets Sales Forecast by Country (2023-2028) & (M Unit)
Table 84. Middle East & Africa Oxcarbazepine Tablets Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Oxcarbazepine Tablets Sales Forecast by Type (2023-2028) & (M Unit)
Table 86. Global Oxcarbazepine Tablets Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Oxcarbazepine Tablets Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Oxcarbazepine Tablets Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Oxcarbazepine Tablets Sales Forecast by Application (2023-2028) & (M Unit)
Table 90. Global Oxcarbazepine Tablets Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Oxcarbazepine Tablets Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Oxcarbazepine Tablets Revenue Market Share Forecast by Application (2023-2028)
Table 93. Novartis (Trileptal) Basic Information, Oxcarbazepine Tablets Manufacturing Base, Sales Area and Its Competitors
Table 94. Novartis (Trileptal) Oxcarbazepine Tablets Product Offered
Table 95. Novartis (Trileptal) Oxcarbazepine Tablets Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 96. Novartis (Trileptal) Main Business
Table 97. Novartis (Trileptal) Latest Developments
Table 98. Supernus Pharmaceuticals (Oxtellar XR) Basic Information, Oxcarbazepine Tablets Manufacturing Base, Sales Area and Its Competitors
Table 99. Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Tablets Product Offered
Table 100. Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Tablets Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 101. Supernus Pharmaceuticals (Oxtellar XR) Main Business
Table 102. Supernus Pharmaceuticals (Oxtellar XR) Latest Developments
Table 103. Apotex Basic Information, Oxcarbazepine Tablets Manufacturing Base, Sales Area and Its Competitors
Table 104. Apotex Oxcarbazepine Tablets Product Offered
Table 105. Apotex Oxcarbazepine Tablets Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 106. Apotex Main Business
Table 107. Apotex Latest Developments
Table 108. Sun Pharm Basic Information, Oxcarbazepine Tablets Manufacturing Base, Sales Area and Its Competitors
Table 109. Sun Pharm Oxcarbazepine Tablets Product Offered
Table 110. Sun Pharm Oxcarbazepine Tablets Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 111. Sun Pharm Main Business
Table 112. Sun Pharm Latest Developments
Table 113. Jubilant Generics Basic Information, Oxcarbazepine Tablets Manufacturing Base, Sales Area and Its Competitors
Table 114. Jubilant Generics Oxcarbazepine Tablets Product Offered
Table 115. Jubilant Generics Oxcarbazepine Tablets Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 116. Jubilant Generics Main Business
Table 117. Jubilant Generics Latest Developments
Table 118. Taro Pharmaceuticals Basic Information, Oxcarbazepine Tablets Manufacturing Base, Sales Area and Its Competitors
Table 119. Taro Pharmaceuticals Oxcarbazepine Tablets Product Offered
Table 120. Taro Pharmaceuticals Oxcarbazepine Tablets Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 121. Taro Pharmaceuticals Main Business
Table 122. Taro Pharmaceuticals Latest Developments
Table 123. Stada Group Basic Information, Oxcarbazepine Tablets Manufacturing Base, Sales Area and Its Competitors
Table 124. Stada Group Oxcarbazepine Tablets Product Offered
Table 125. Stada Group Oxcarbazepine Tablets Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 126. Stada Group Main Business
Table 127. Stada Group Latest Developments
Table 128. Mylan Basic Information, Oxcarbazepine Tablets Manufacturing Base, Sales Area and Its Competitors
Table 129. Mylan Oxcarbazepine Tablets Product Offered
Table 130. Mylan Oxcarbazepine Tablets Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 131. Mylan Main Business
Table 132. Mylan Latest Developments
Table 133. Teva Pharmaceutical Basic Information, Oxcarbazepine Tablets Manufacturing Base, Sales Area and Its Competitors
Table 134. Teva Pharmaceutical Oxcarbazepine Tablets Product Offered
Table 135. Teva Pharmaceutical Oxcarbazepine Tablets Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 136. Teva Pharmaceutical Main Business
Table 137. Teva Pharmaceutical Latest Developments
Table 138. Hikma Pharmaceuticals Basic Information, Oxcarbazepine Tablets Manufacturing Base, Sales Area and Its Competitors
Table 139. Hikma Pharmaceuticals Oxcarbazepine Tablets Product Offered
Table 140. Hikma Pharmaceuticals Oxcarbazepine Tablets Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 141. Hikma Pharmaceuticals Main Business
Table 142. Hikma Pharmaceuticals Latest Developments
Table 143. ANI Pharmaceuticals Basic Information, Oxcarbazepine Tablets Manufacturing Base, Sales Area and Its Competitors
Table 144. ANI Pharmaceuticals Oxcarbazepine Tablets Product Offered
Table 145. ANI Pharmaceuticals Oxcarbazepine Tablets Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 146. ANI Pharmaceuticals Main Business
Table 147. ANI Pharmaceuticals Latest Developments
Table 148. Glenmark Pharmaceuticals Basic Information, Oxcarbazepine Tablets Manufacturing Base, Sales Area and Its Competitors
Table 149. Glenmark Pharmaceuticals Oxcarbazepine Tablets Product Offered
Table 150. Glenmark Pharmaceuticals Oxcarbazepine Tablets Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 151. Glenmark Pharmaceuticals Main Business
Table 152. Glenmark Pharmaceuticals Latest Developments
Table 153. Roxane Laboratories Basic Information, Oxcarbazepine Tablets Manufacturing Base, Sales Area and Its Competitors
Table 154. Roxane Laboratories Oxcarbazepine Tablets Product Offered
Table 155. Roxane Laboratories Oxcarbazepine Tablets Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 156. Roxane Laboratories Main Business
Table 157. Roxane Laboratories Latest Developments
Table 158. Nobelpharma Basic Information, Oxcarbazepine Tablets Manufacturing Base, Sales Area and Its Competitors
Table 159. Nobelpharma Oxcarbazepine Tablets Product Offered
Table 160. Nobelpharma Oxcarbazepine Tablets Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 161. Nobelpharma Main Business
Table 162. Nobelpharma Latest Developments
Table 163. Jamp Pharma Basic Information, Oxcarbazepine Tablets Manufacturing Base, Sales Area and Its Competitors
Table 164. Jamp Pharma Oxcarbazepine Tablets Product Offered
Table 165. Jamp Pharma Oxcarbazepine Tablets Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 166. Jamp Pharma Main Business
Table 167. Jamp Pharma Latest Developments
Table 168. Neuraxpharm Basic Information, Oxcarbazepine Tablets Manufacturing Base, Sales Area and Its Competitors
Table 169. Neuraxpharm Oxcarbazepine Tablets Product Offered
Table 170. Neuraxpharm Oxcarbazepine Tablets Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 171. Neuraxpharm Main Business
Table 172. Neuraxpharm Latest Developments
Table 173. Orion Corporation Basic Information, Oxcarbazepine Tablets Manufacturing Base, Sales Area and Its Competitors
Table 174. Orion Corporation Oxcarbazepine Tablets Product Offered
Table 175. Orion Corporation Oxcarbazepine Tablets Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 176. Orion Corporation Main Business
Table 177. Orion Corporation Latest Developments
Table 178. SihuanPharm Basic Information, Oxcarbazepine Tablets Manufacturing Base, Sales Area and Its Competitors
Table 179. SihuanPharm Oxcarbazepine Tablets Product Offered
Table 180. SihuanPharm Oxcarbazepine Tablets Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 181. SihuanPharm Main Business
Table 182. SihuanPharm Latest Developments
Table 183. Humanwell Healthcare Basic Information, Oxcarbazepine Tablets Manufacturing Base, Sales Area and Its Competitors
Table 184. Humanwell Healthcare Oxcarbazepine Tablets Product Offered
Table 185. Humanwell Healthcare Oxcarbazepine Tablets Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 186. Humanwell Healthcare Main Business
Table 187. Humanwell Healthcare Latest Developments
Table 188. Huikang Pharmaceutical Basic Information, Oxcarbazepine Tablets Manufacturing Base, Sales Area and Its Competitors
Table 189. Huikang Pharmaceutical Oxcarbazepine Tablets Product Offered
Table 190. Huikang Pharmaceutical Oxcarbazepine Tablets Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 191. Huikang Pharmaceutical Main Business
Table 192. Huikang Pharmaceutical Latest Developments
Table 193. Nexgen pharma Basic Information, Oxcarbazepine Tablets Manufacturing Base, Sales Area and Its Competitors
Table 194. Nexgen pharma Oxcarbazepine Tablets Product Offered
Table 195. Nexgen pharma Oxcarbazepine Tablets Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 196. Nexgen pharma Main Business
Table 197. Nexgen pharma Latest Developments
List of Figures
Figure 1. Picture of Oxcarbazepine Tablets
Figure 2. Oxcarbazepine Tablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oxcarbazepine Tablets Sales Growth Rate 2017-2028 (M Unit)
Figure 7. Global Oxcarbazepine Tablets Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Oxcarbazepine Tablets Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Tablets (150mg)
Figure 10. Product Picture of Tablets (300mg)
Figure 11. Product Picture of Tablets (600mg)
Figure 12. Global Oxcarbazepine Tablets Sales Market Share by Type in 2021
Figure 13. Global Oxcarbazepine Tablets Revenue Market Share by Type (2017-2022)
Figure 14. Oxcarbazepine Tablets Consumed in Hospital Pharmacy
Figure 15. Global Oxcarbazepine Tablets Market: Hospital Pharmacy (2017-2022) & (M Unit)
Figure 16. Oxcarbazepine Tablets Consumed in Retail Pharmacy
Figure 17. Global Oxcarbazepine Tablets Market: Retail Pharmacy (2017-2022) & (M Unit)
Figure 18. Oxcarbazepine Tablets Consumed in Online Pharmacy
Figure 19. Global Oxcarbazepine Tablets Market: Online Pharmacy (2017-2022) & (M Unit)
Figure 20. Global Oxcarbazepine Tablets Sales Market Share by Application (2017-2022)
Figure 21. Global Oxcarbazepine Tablets Revenue Market Share by Application in 2021
Figure 22. Oxcarbazepine Tablets Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Oxcarbazepine Tablets Revenue Market Share by Company in 2021
Figure 24. Global Oxcarbazepine Tablets Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Oxcarbazepine Tablets Revenue Market Share by Geographic Region in 2021
Figure 26. Global Oxcarbazepine Tablets Sales Market Share by Region (2017-2022)
Figure 27. Global Oxcarbazepine Tablets Revenue Market Share by Country/Region in 2021
Figure 28. Americas Oxcarbazepine Tablets Sales 2017-2022 (M Unit)
Figure 29. Americas Oxcarbazepine Tablets Revenue 2017-2022 ($ Millions)
Figure 30. APAC Oxcarbazepine Tablets Sales 2017-2022 (M Unit)
Figure 31. APAC Oxcarbazepine Tablets Revenue 2017-2022 ($ Millions)
Figure 32. Europe Oxcarbazepine Tablets Sales 2017-2022 (M Unit)
Figure 33. Europe Oxcarbazepine Tablets Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Oxcarbazepine Tablets Sales 2017-2022 (M Unit)
Figure 35. Middle East & Africa Oxcarbazepine Tablets Revenue 2017-2022 ($ Millions)
Figure 36. Americas Oxcarbazepine Tablets Sales Market Share by Country in 2021
Figure 37. Americas Oxcarbazepine Tablets Revenue Market Share by Country in 2021
Figure 38. United States Oxcarbazepine Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Oxcarbazepine Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Oxcarbazepine Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Oxcarbazepine Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Oxcarbazepine Tablets Sales Market Share by Region in 2021
Figure 43. APAC Oxcarbazepine Tablets Revenue Market Share by Regions in 2021
Figure 44. China Oxcarbazepine Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Oxcarbazepine Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Oxcarbazepine Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Oxcarbazepine Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Oxcarbazepine Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Oxcarbazepine Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Oxcarbazepine Tablets Sales Market Share by Country in 2021
Figure 51. Europe Oxcarbazepine Tablets Revenue Market Share by Country in 2021
Figure 52. Germany Oxcarbazepine Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Oxcarbazepine Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Oxcarbazepine Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Oxcarbazepine Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Oxcarbazepine Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Oxcarbazepine Tablets Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Oxcarbazepine Tablets Revenue Market Share by Country in 2021
Figure 59. Egypt Oxcarbazepine Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Oxcarbazepine Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Oxcarbazepine Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Oxcarbazepine Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Oxcarbazepine Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Oxcarbazepine Tablets in 2021
Figure 65. Manufacturing Process Analysis of Oxcarbazepine Tablets
Figure 66. Industry Chain Structure of Oxcarbazepine Tablets
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...